MEGAN WALPOLE: Open Payments
NPI 1841439387 · UNION CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 22 payments from 11 companies in 2025. Trend: 2023 $874 · 2024 $444 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $59 |
| PFIZER INC. | 3 | $59 |
| Insulet Corporation | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Dexcom, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: TRINTELLIX, NURTEC ODT, Omnipod, REXULTI, VRAYLAR, XIFAXAN, Dexcom G6 Transmitter, FANAPT.
Industry payments across GA — which companies pay providers there.
